Fundz

Roche-Backed Freenome Continues Industry’s Private Funding Rally with $254M Raise

PUBLIC · FRNMFeb 15, 2024

Amount Raised

$254 Million

Round Type

Series A

BrisbaneBiotechnologyHealth CareScience And EngineeringVenture CapitalLife Science

Investors

American Cancer Society’s Bright Edge VenturesArk InvestmentsCormorant CapitalBain Capital Life SciencesRoche

Description

Freenome announced a $254 million private financing round, led by Roche, to support the development of its multiomics-based early detection tests for cancer.

Quick answer

Freenome raised $254 Million in a Series A round, dated February 15, 2024. Investors: American Cancer Society’s Bright Edge Ventures, Ark Investments, Cormorant Capital, Bain Capital Life Sciences and Roche. Freenome is based in Brisbane, California, United States.

How much did Freenome raise?
Freenome raised $254 Million in a Series A round on February 15, 2024.
Who invested in Freenome?
American Cancer Society’s Bright Edge Ventures, Ark Investments, Cormorant Capital, Bain Capital Life Sciences and Roche are named as investors in this round.
What does Freenome do?
Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw.
Where is Freenome based and how big is it?
Freenome is based in Brisbane, California, United States. Fundz records about 396 employees.
Who are the decision-makers at Freenome?
Fundz holds 1 contact at Freenome. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Venture Capital around the same time

Companies in the same sectors as Freenome that raised within 45 days of this round, from Fundz verified event records.

  • Enliven Therapeutics raised $90M on March 21, 2024.
  • Enliven Therapeutics raised $90M (Post-IPO Equity) on March 20, 2024.
  • Aprea Therapeutics raised $34M (Funding Round) on March 18, 2024.
  • Zephyr AI, Inc. raised $111M (Series A) on March 13, 2024.
  • Aprea Therapeutics raised $34M (Post-IPO Equity) on March 12, 2024.
  • MAIA Biotechnology raised $2.9M (Seed) on March 11, 2024.

Who to call at Freenome, and when

A new round usually means Freenome is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Freenome raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Freenome, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Freenome. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Freenome

Location

Brisbane, California, United States

About

Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. 1 Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC. Vital Signs: Colorectal Cancer Screening Test Use — United States, 2018. MMWR Morb Mortal Wkly Rep 2020;69:253–259. 2 United States Preventive Services Task Force (USPSTF), "Colorectal Cancer: Screening", May 18, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening SOURCE Freenome Holdings, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Freenome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Freenome's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Freenome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.